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Introduction: Harmful usage of tobacco is a public health problem of global concern and,
in many countries, the main risk factor for non-communicable diseases. Yet, in the
Peruvian Amazon, the geographical region believed to be tobacco’s historical birthplace,
this plant is associated with a strikingly different usage and repute: Tobacco (especially
Nicotiana rustica L.) in this area is described as a potent medicinal plant, used topically or
via ingestion to treat a variety of health conditions. The goal of this transdisciplinary field
study was to investigate clinical applications of the tobacco plant as per Amazonian
medicine exemplified in the practice of a reputed Maestro Tabaquero, an Amazonian
traditional healer whose medical specialization focuses on tobacco-based treatments.
Methods: Using a transdisciplinary clinical approach, we conducted in-depth interviews
with the tabaquero applying the systematizing expert interview method, in order to map
modes of preparation and administration, indications, contraindications, effects, risks,
adverse effects, and systemic aspects of tobacco-based remedies.
Results: The informant’s descriptions revealed refined knowledge on this plant’s
therapeutic properties and scope, safety profile, and application techniques. The main
indications mentioned included “problems of the mind,” of the respiratory system,
parasitic illnesses (intestinal/skin), gout, and Amazonian epistemic conditions described
as spiritual-energetic in nature. A liquid remedy taken orally was his most commonly used
preparation, with acute/sub-acute effects involving a pronounced psychoactive
component (altered state of consciousness) and physiological response (emesis,
nausea). A skilled tabaquero that knows how to dose, administer, and intervene in case
of adverse effects was considered imperative for safe treatment delivery.in.org October 2020 | Volume 11 | Article 5945911
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Frontiers in Pharmacology | www.frontiersConclusions: To our knowledge, this is the first study employing a transdisciplinary clinical
approach to examine therapeutic applications of tobacco by an Amazonian tabaquero. Our
findings significantly contribute to the growing research literature on Amazonian medicine
and emergent psychedelic-assisted therapies and could, in the long-term, open new
treatment avenues in several domains. Forthcoming studies should assess toxicity/safety
and clinical outcomes of patients receiving Amazonian tobacco-based treatment.Keywords: tobacco, Nicotiana rustica L., Amazon, medicinal plant, Peru, psychoactive, psychedelic-assisted
therapy, traditional medicine (TM)INTRODUCTION
Harmful usage of tobacco (Nicotiana spp.) is considered a public
health problem of global concern, with 1.1 billion smokers
worldwide (World Health Organization, 2017). In many
countries, it is the main risk factor for non-communicable
diseases (Forouzanfar et al., 2015). Yet, in the Amazon, the
geographical region believed to be tobacco’s historical birthplace
(Oyuela-Caycedo and Kawa, 2015), this plant, especially
Nicotiana rustica L., is associated with a strikingly different
usage and repute (Russell, 2019): Tobacco is described as the
main curing tool of Amazonian healers (Barbira-Freedman,
2015) and generally portrayed as a “Master Plant” in this
context (Russell and Rahman, 2015). The ethnographic
literature describes tobacco uses for therapeutic purposes in
conjunction with millennia-old Amerindian traditions
(Wilbert, 1993) and highlights the central role the plant plays
particularly in Amazonian medicine. For the Amazonian natives,
the link between medicine and tobacco is so basic, that the
generic term for “healer” in several local languages is
etymologically linked to the word for “tobacco,” for instance
for the Yuracare ́ people, where korrë-n-chata (i.e., healer)
literally means “he who eats tobacco” (Thomas et al., 2011).
Similarly for the Ashaninka (Russell and Rahman, 2015) and the
Matsigenga (Shepard, 1998) people, whose words for “healer”
(sheripiari and seripigari, respectively) literally translate to “the
one intoxicated by tobacco.” The Amazonian Keshwa people
describe tobacco as the “father of all plants” (Barbira-Freedman,
2010; Barbira-Freedman, 2015). The latter description is not
unlike informal accounts from our own previous fieldwork
where tobacco was referenced as the “director of all medicinal
plants.” In light of these descriptions, it seems striking that this
plant in the rest of the world is used as a recreational drug, with
tobacco smoking being the most prevalent addictive behavior
across the planet (Martin-Soelch, 2013; Gowing et al., 2015).
Tobacco’s historical migration from indigenous Latin
America and its transformation from local medicinal plant to
global substance of abuse ensued via its rapid popularization
among Spaniards after the colonial arrival on the American
continent: The plant was introduced to Europe in the late 15th
century, where it was readily adopted, and an extensive chain of
trade later stretching to Africa and Asia took its course (Oyuela-
Caycedo and Kawa, 2015). Notwithstanding an initial interest in
tobacco’s medicinal possibilities among the new users (Charlton,
2004), tobacco’s large-scale commodification and global spreadin.org 2brought forth novel consumption patterns, recreational uses,
which—in stark contrast to the plant’s native origins in
indigenous healing—turned out to have deleterious health
outcomes, as today is well known (Russell and Rahman, 2015;
West, 2017). That the plant has traveled to the West without the
corresponding indigenous know-how on its medical uses could
be hypothesized to have played a role in these developments.
Traditional medicines, defined as “knowledge, skill and
practices based on the theories, beliefs and experiences
indigenous to different cultures, whether explicable or not,
used in the maintenance of health, as well as in the prevention,
diagnosis, improvement or treatment of physical and mental
illnesses” (p.8, WHO, 2019), play an increasingly central role in
global modern healthcare, particularly for chronic conditions
like cancer, diabetes, or chronic pain (Molassiotis et al., 2005;
Turk et al., 2011; Ablin et al., 2013; WHO, 2013; Falci et al., 2016;
Charlier et al., 2017). The WHO (2019) considers its inclusion
to global primary healthcare as pivotal for achieving their
declared goal of Universal Health Coverage and the Sustainable
Development Goals (United Nations, 2015). This is particularly
relevant also for the psychosomatic and mental health domain
(Gureje et al., 2015), where treatments are known to be markedly
underprovided on a global scale (see worldwide treatment gap in
mental health; Kohn et al., 2004; WHO, 2008; Evans-Lacko et al.,
2017) and where chronicity is common (Costello et al., 2002;
Brandon et al., 2007; Koob and Le Moal, 2008; WHO, 2008).
Among traditional medical systems currently investigated for
mental health, especially the Amazonian tradition and its
psychoactive ayahuasca brew (Banisteriopsis caapi and varying
admixture plants; Riba et al., 2003; McKenna, 2004) have
recently become the center of scientific attention across the
globe (Feeney et al., 2018; Hamill et al., 2018; Labate and
Cavnar, 2018). Clinical research in this context has been
burgeoning over the last years, alongside research on other
psychoactive substances (see also “psychedelic-assisted
therapies”; Tupper et al., 2015; Johnson et al., 2019), with
growing evidence showing ayahuasca to benefit affective
disorders, substance use, anxiety disorders, and other
conditions (Thomas et al., 2013; Labate and Cavnar, 2014;
Osorio Fde et al., 2015; dos Santos et al., 2016; Nunes et al.,
2016; Coe and McKenna, 2017; Domıńguez-Clavé et al., 2018;
Palhano-Fontes et al., 2018; Renelli et al., 2018; Berlowitz et al.,
2019). However, notwithstanding the considerable global interest
in ayahuasca and Amazonian medicine, the nature and place of
tobacco-based treatments within this medical system have so farOctober 2020 | Volume 11 | Article 594591
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Amazonian medicine has yet systematically examined these
uses—in spite of the central role the anthropological literature
ascribes to this plant in Amazonian healing (Valadeau et al.,
2010; Barbira-Freedman, 2015). Also in a more general sense,
even though tobacco as medicine and mind-altering substance is
ubiquitously found in ethnographic accounts of Amerindian
societies, its therapeutic uses have received remarkably little
scholarly attention thus far (Russell and Rahman, 2015).
The overall goal of the current study was to document in
detail how the tobacco plant is used in Peruvian Amazonian
medicine as exemplified in the practice of an Amazonian
specialist or Maestro Tabaquero, a reputed Amazonian healer
whose medical specialization focuses on tobacco uses (Valadeau
et al., 2010). More specifically, performing in-depth interviews in
the scope of a transdisciplinary collaboration (Jahn et al., 2012),
we aimed to report indications, contraindications, modes of
preparation and application, short- and long-term effects, risks,
and adverse effects of tobacco-based treatments; we further
aimed to understand the contextual or systemic aspects of how
this plant relates to other treatment constituents of Amazonian
medicine as a system.METHODS
The systematizing expert interview method (Bogner and Menz,
2009) was employed to collect in-depth information on the above
topics using a single-respondent key informant design (Tremblay,
1957; Sandelowski, 1996; Meuser and Nagel, 2009a). An expert is
defined as a person who, due to her/his experience or position, is
in the possession of special knowledge regarding a socially relevant
field; the expert interview, then, is a method for gaining access to
this special knowledge or expertise (Gläser and Laudel, 2010). This
interviewing method requires the interviewer to be knowledgeable
in the subject at hand (Meuser and Nagel, 2009b), otherwise the
interviewee may avoid complex terrain (expecting the interviewer
to be insufficiently competent to understand it) and share only
superficial information. Given the multi-epistemic context of this
study, an interviewer who is a relevant specialist from a different
knowledge culture (Bogner and Menz, 2009)—namely a scientist
in clinical and health psychology with experience in investigating
Amazonian medicine (first author of this paper; e.g., Berlowitz
et al., 2017; Berlowitz et al., 2019)—was considered most suitable.
This allowed equitable dialogue and in-depth exploration
of knowledge, including aspects that differ in the two
epistemic domains.
Given the scarcity of literature presently available on the
subject and thus exploratory nature of this work, and in light of
this study’s clinical focus as opposed to anthropological (i.e., of
interest is clinical depth rather than cultural representativeness),
a single-respondent design involving continual sittings over an
extended period of time was chosen in favor of a multiple
respondents design with one sitting each (Etkin, 1993;
Sandelowski, 1996; Bengtsson, 2016). A high level of
information power (Malterud et al., 2016) was nonetheless
safeguarded by selecting a highly accomplished and specializedFrontiers in Pharmacology | www.frontiersin.org 3clinical expert as the key informant of this study (Gläser and
Laudel, 2010; Krause et al., 2018).
Instrument
A comprehensive semi-structured interview schedule was
developed via a methodological procedure described by Kallio
et al. (2016): We generated an ample set of guiding questions to
cover the different content areas of the research subject, drawing
from ethno-medical field research and classification methods
(Lipp, 1989; Staub et al., 2015), our previous research experience
and the anthropological literature on Amazonian medicine and
tobacco uses (Wilbert, 1993; Russell and Rahman, 2015;
Berlowitz, 2017), as well as general psychological/somatic
symptom category systems (Schinka, 1989; Derogatis and
Unger, 2010). The resulting inventory was handed to an
interdisciplinary expert panel for assessment consisting of
scientific advisors from medicine, psychology, complementary
medicine, biology, and medical anthropology, and was adapted
accordingly. The semi-structured format was chosen due to the
open, co-creative ambiance it generates in the interviewing
process (new topics and follow-up questions may be
improvised by both parties), which in turn increases breadth
and depths of material (deMarrais and Lapan, 2003). The final
interview schedule consisted of nine chapters (see Table 1), each
made of sub-chapters with several probing questions. The full
schedule can be obtained from the authors upon request.
Key Informant
The informant was a 51-year-old Amazonian traditional healer
(curandero) and Maestro Tabaquero with 36 years of clinical
experience. He is from Peru, but of mixed Amazonian ancestry,
as his four grandparents were originally from Peruvian, Colombian,
Ecuadorian, and Brazilian Amazonian areas, respectively. Born at
the banks of the Peruvian Rıó Tigre (Loreto Province), the
informant was raised by his maternal grandparents who were
traditional healers and farmers. He was instructed by his
grandparents from an early age on and started to train more
formally at age 8, via extended forest retreats (dietas; solitary
retreats designed to experientially study medicinal plants), as is
customary in the training of an Amazonian healer. At age 12 he
discovered his calling to specialize as a tabaquero, after having been
initiated into the tobacco medicine by his Peruvian grandfather. He
recalls starting to regularly attend to patients at age 15, but he
continued to develop his knowledge and skill in the field of healing
and tobacco-based treatments throughout his life, also including
periods of study with Amazonian healers other than his
grandparents. He progressively attained expert status in the field
of tobacco medicine and the reputation of a Maestro, a highly
esteemed Amazonian healer. Today he attends regional, national, as
well as international patients at his practice in Loreto, offering
treatments using tobacco-based medicines in the scope of one-time
consultations, individual retreat-like treatments, and occasionally
also group work.
Data Collection Procedure
A total of eight interview sessions were held between October
2019 and July 2020 after written informed consent wasOctober 2020 | Volume 11 | Article 594591
Berlowitz et al. Tobacco-Based Treatments in Amazonian Medicineobtained from the informant. Interviews were conducted face
to face at the informant’s workplace in Loreto (Peru) except for
the last session, which was conducted long-distance (over the
phone) due to the COVID-19 pandemic. All sessions were held
in Spanish (native language of the informant). Interviewing
was repeated as long as relevant new materials continued to
emerge, and was discontinued when the level of depth reached
was considered satisfactory (depth defined in terms of detail
and completeness, Weiss, 1994; deMarrais and Lapan, 2003,
akin to the concept of saturation, Morse, 1995; Saunders et al.,
2018). In order to facilitate subsequent transcription of the
material all interview sessions were audio-recorded, with the
informant’s permission. The study was approved by the ethics
committee (2019; Ref-No.:88A1; Fribourg) and conducted in
accordance with international regulations and the Declaration
of Helsinki.
Data Analysis
The audio-recorded interview sessions were transcribed
verbatim and analyzed using a manifest content analytic
approach, aimed to condense the rich information conveyed by
the informant and systematize it relative to the main interviewFrontiers in Pharmacology | www.frontiersin.org 4questions (Graneheim and Lundman, 2004; Mayring, 2008;
Bengtsson, 2016). A preliminary category system made of
seven themes (see Results) was initially developed based on the
interview questions and adaptations during the data collection
process. The textual material was carefully analyzed and
structured along those themes in a first analytic step.
Additional relevant themes that emerged during this process
were added to the category system inductively in a second step;
additionally, if the material suggested so, adjustments were made
to the foci of predefined themes (e.g., narrowing, broadening,
further differentiating, merging, or splitting multifaceted
clusters). Once the final category system consisting of nine
themes (see next section) was established, the overall material
was classified again using this category system in a final step.RESULTS
The themes initially defined based on the interview questions
were (in slightly adapted form): Manners of preparation and
modes of application; Experienced short-, mid-, and long-term
effects; Applications in the physical health domain; Applications
in the mental health and psychosomatic domain; The tobacco’s
spiritual-energetic properties and applications in Amazonian
epistemic health domains; Contraindications, interactions,
risks, and adverse effects; and Tobacco in relation to other
Amazonian medicinal plants. The first two themes mentioned
were split into two distinct categories in the course of the analytic
process, and an emergent theme (Uses of tobacco smoke in the
work of a Tabaquero and Amazonian medicine) was added. For
each theme, a condensed summary of contents is presented,
along with quotes to exemplify or illustrate the material in the
words of the healer. Some details provided by the informant were
omitted from the report in order to protect the intellectual
property of traditional knowledge by this healer and the
Amazonian medical tradition overall (see also Nagoya
protocol, Buck and Hamilton, 2011). Especially precise recipes
are not provided here, so as to protect the intellectual property of
traditional knowledge. Moreover, the Tabaquero also expressed
concern that if recipes were to be made public, readers could get
tempted to experiment with tobacco on themselves or others,
which would be highly dangerous.
Therapeutic Uses of the Tobacco
Plant: Manners of Preparation and
Routes of Administration
The healer explains that he relies primarily on leaves of N. rustica
L. for preparing his remedies, but that other parts of the plant are
also useful for certain problems (e.g., the root applied on dogs for
skin worms). “The tobacco [I use] is prepared of leaves, it is
called cured, it has a process of curing the leaves, and once they
have a color between black and brown, they are ready to be used.”
He reports making liquid and solid remedies from this tobacco,
some for ingestion, others for topical application (see Table 2).
The Tabaquero reports using many “varieties of preparations
and combinations of medicinal plants” in conjunction withTABLE 1 | Chapters and subchapters of the interview schedule.
Part 1: Training in Amazonian medicine/Tabaquerismo and details of informant
1.1. Training in traditional Amazonian medicine and specialization in tobacco
1.2. Basic sociodemographic data
Part 2: Systemic aspects
2.1. The Tabaquero/a as Amazonian specialist in the medical usage of tobacco
2.2. Tobacco in relation to the rest of the traditional Amazonian medical system
Part 3: Modes of preparation and manners of application
3.1. Liquid preparation for ingestion
3.2. Manners of application of liquid tobacco
3.3. Solid preparation for ingestion
3.4. Topical application
3.5. Smoked form
Part 4: Short- and long-term effects of ingested liquid tobacco
4.1. Physical effect profile
4.2. Emotional effect profile
4.3. Cognitive effect profile
4.4. Other domains of effects
4.5. Dose-dependent effects
Part 5: Indications for tobacco-based medicines
5.1. Mental health domain
5.2. Amazonian epistemic domain
5.3. Physical health domain
5.4. Other health-related domains
Part 6: Contraindications for tobacco-based medicines for ingestion
6.1. Physical
6.2. Psychological
6.3. Specific life circumstances
Part 7: Diagnostic procedures and treatment choice
7.1. Determination of indicated type of medicine
Part 8: Risks, adverse effects, and interactions
8.1. Adverse effects
8.2. Risks
8.3. Interactions with other substances
Part 9: Broader perspective and final considerations
9.1. Broader perspective on tobacco uses
9.2. Final considerationsEach subchapter consisted of a number of questions and probes in the full
interview schedule.October 2020 | Volume 11 | Article 594591
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to target. Liquid preparations for ingestion are what he uses most
frequently. Unless otherwise stated, the following sections will
therefore focus on this type of remedy.
The healer uses oral, nasal, or topical routes of administration
for his tobacco remedies. In case of the nasal route he uses liquid,
but not solid tobacco snuff, as he considers the latter (today often
called rape)́ to have certain disadvantages. For topical application
he uses tobacco leaves, either as a cataplasm or processed with
other plants as an ointment or in the form of a medicated shower
(“baño de plantas”). He does not employ enemas of tobacco, but
states that this is a common practice in the Amazon and may be
useful for instance for intestinal parasites. Finally, he makes use
of the leaves in smoked form for “energetic purposes,” as he
explains, a concept which will be further described in
forthcoming sections.
Modes of Application: Dosage and
Ritual Context
Dosage is determined as a function of type of illness and
constitution of a person’s body, nervous system, and energy,
the healer explains. An oral tobacco dose can range from
minuscule to large, and a thorough diagnostic analysis
beforehand is critical, the healer asserts: A tabaquero must
learn the traditional Amazonian techniques (e.g., pulsar, see
also Contraindications, Interactions, Risks, and Adverse Effects)
for this purpose during his training, explains the healer. He must
also learn the Amazonian ritual techniques for correctly
administering the medicine (e.g., soplar, icarar, see Uses of
Tobacco Smoke in the Work of a Tabaquero and Amazonian
Medicine), and the methods for intervening in case of adverse
reactions to the tobacco effect (see Contraindications,
Interactions, Risks, and Adverse Effects). He portrays these
methods as a pivotal part of the safety protocol for using
medicinal tobacco securely.
The healer describes several different contexts for
administering oral tobacco, depending on the type of
preparation and illness. For “strong preparations” he conducts
tobacco ceremonies, which can be held for an individual or in a
group setting, or he administers the tobacco in the scope of
Amazonian dietary retreats (traditionally called dieta). The latter
involves a period of several days of social seclusion, strict dietary
regime, and daily tobacco ingestion. In yet other cases he may
prescribe a tobacco preparation combined with further medicinal
plants that target specific health problems. For all of these threeFrontiers in Pharmacology | www.frontiersin.org 5contexts, however, a specific dietary regime is mandatory: On the
days of tobacco ingestion the regime is strict, and for several days
to weeks after the treatment, specific foods and behaviors need to
be avoided. “Also, one has to know how to eat,” the healer adds,
implying that an overall healthy diet during this timeframe
is important.
Experienced Short-, Mid-, and
Long-Term Effects
The healer states that the felt effect of tobacco heavily depends on
the specific mode of preparation. He goes on to describe the
sequence of effects typically experienced in the context of the
“strong” tobacco preparation used in the ceremonial or dietary
context: The first effects may set in quite immediately or after a
few minutes, the onset being experienced either abruptly (“an
internal blow”), or more gradually as an intensifying malaise.
The patient may experience an inner tension with typical bodily
sensations (dizziness, nausea, weakness) and cognitive/affective
unease, a process which then culminates in vomiting. This
tobacco-induced emesis gives way to a next effect phase, in
which an inner sense of relaxation, coupled with introspective
mental activity, tends to be experienced. The healer describes:
“About 30 minutes after having ingested the tobacco, after
having vomited, there is an opening of the psychic-mental. The
person starts to reflect and there are like stories surfacing,
possibly from childhood. This is because the psychic-mental
has opened—a bit like a memory chip of a cell phone where there
is information. And there the person will see or feel a lot of bad
things, and a lot of good things. These things are not perceptions
of something external, but they are emerging from their own
mind, it is their mind that is releasing or liberating things. These
are the effects. And later on, if the body and the tobacco have
aligned, the person feels a sort of inner peace. It has this effect.”
He describes that memories, emotions, and thoughts are
surfacing in this phase and “if someone knows a bit of
concentration, there may also be visions.” This progression of
effects may take approximately 2 h, he explains, after which the
intense effect wanes but remains in a mild form. Vivid dreams
are common in the sleep thereafter, the healer explains, often
with personally meaningful contents.
He describes that in the days or week that follow, one typically
discovers a more positive outlook on life, a more joyful general
attitude. Prior negative tendencies of the mind have greatly
lessened and “a positive mind-state gets strengthened.” On an





Topical Medicated shower with tobacco leaves Cataplasms or salve/paste, applied on
affected area
Soplada on defined energy points of patient body
(akin to acupoints)
Oral Ingestion; most commonly used method by
informant
Tabaqueros only (not used for
patients)
Tabaqueros only (smoke swallowed rather than
inhaled)
Intranasal Liquid snuff; often combined with oral route Pulverized tobacco snuff (not used by
informant)
(some passive nasal inhalation may occur during
sopladas)
Rectal Tobacco-based enema (not used by informant) – –October 2020 | Volume 11 | Article 594591
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up. The person may experience more love, love towards nature,
animals, or people. It opens a state of feeling which may be new
to that person; they may be happy, or cry for example.”
The nature of long-term therapeutic benefits of tobacco-based
remedies generally depends on the specific illness targeted (see
the following 3 sections), but if administered for cleansing
purposes, an occasional repetition is necessary, to prevent new
accumulations of toxins in the body-mind system, so to speak:
“So, since the contemporary world is quite contaminated, in
different ways, it is necessary to continually liberate and clean
these energies. [ … ] Like a machine that needs regular
maintenance, something like that.”
Applications in the Physical
Health Domain
The healer lists problems of the respiratory system like sinusitis,
gout, parasitic illnesses of intestines, and epilepsy as the main types
of physical health problems that he treats with tobacco. He
specifies that “there is a process for preparing the tobacco which
makes it into effective medicine for the lungs. In other uses it may
become a poison for the lungs, but if it is processed in the right
manner, it is medicine, it cures; the tobacco absorbs phlegm and
removes it [from the respiratory system].”He goes on to describe a
different manner of preparation, which he uses for treating
intestinal parasites; a remedy that “is like a purge, it gives you
diarrhea, it cleans [the intestines].” He explains that in general,
tobacco is a hot or heating herb. It is therefore apt to treat inner
cold conditions, but not suited for conditions associated with inner
heat. Gases in the intestines that arise due to excessive cold, he
exemplifies, can effectively be treated with tobacco; yet tobacco is
not advised for an acute inflammation in the intestines.
The healer points to the interplay between the physical and
psychological domains in this context. He describes the existence
of a direct connection between intestines and brain, with a chain
reaction occurring on account of this linkage when drinking
tobacco: “Physically it [the tobacco] cleans the intestines of
parasites and negative energies, but because the intestines
connect to the brain, if the intestines get liberated, the brain
gets liberated as well.” This manifests as improvements to
psychological well-being (see next section). He explains that
similarly, when mucus and phlegm that block the respiratory
pathways get expelled with the help of tobacco, there is an
increase of oxygen flow which leads to an “opening of the
brain” and an easing or clearing of the mind: “For many
foreigners that are [psychologically] unwell, it is because the
brain is closed off of oxygen. Only very little can pass and that is
why they feel bad. This is why the tobacco helps, when it makes
you vomit and spit out the phlegm, the phlegm that gets removed
unblocks the pathways here, and here [pointing to specific spots
on the body], and then the person sees things differently.”
Another type of tobacco preparation is effective for gout, he
continues, a condition he relates to inner cold. Further, topical
application of a tobacco ointment is helpful for parasites of the
skin. A specific preparation of tobacco combined with other
ingredients is used to treat epilepsy. Finally, the healer adds thatFrontiers in Pharmacology | www.frontiersin.org 6tobacco has benefits also for a generally healthy person, because
it fortifies and detoxifies the body. This is why traditionally it is
employed also as a preventative or maintenance mechanism to
prevent future illness.
Taking the concept of physical health domain in a broader
sense (i.e., beyond human anatomy), the healer describes using
tobacco also in veterinary medicine, especially for dogs, for
instance for parasitic illnesses (skin or intestinal), but it can
also be administered to enhance their olfactory sense: “In case of
the dog, [the tobacco] is applied in his nose. In the nose because
it makes him smell other animals from a large distance. The dog
becomes an excellent hunter.” The healer adds that a similar
effect, i.e., an increase in sensory acuity also happens for humans
that ingest tobacco, but that they may often not notice it. Finally,
he adds that tobacco can be used for the health of crops, for
instance if a plant gets infected with a pest, tobacco may be
sprayed on it.
Applications in the Mental Health and
Psychosomatic Domain
The healer continually describes that the tobacco remedy
“centers” or “strengthens” the mind. Correspondingly, among
the chief indication for this medicine he points to “problems of
the mind” or of the “psychic-mental system.” According to his
descriptions this can include clinical or subclinical mental health
issues, but excludes certain severe psychiatric conditions, for
which tobacco is contraindicated. He describes therapeutic
benefits for psychological processes related to attention (“some
people think, and later they forget; others don’t think at all—
these things the tobacco helps to clear, or open”), cognitive
tendencies (“if previously a person had a destructive mind, [after
the tobacco-treatment] they don’t have it anymore, the mind is
more constructive, there is a change”), mood and self-image (“a
person with a very low self-esteem, if they drink tobacco the self-
esteem gets lifted, the tobacco can help”; “the person feels more
cheerful, more serene”), as well as fearfulness (“[the tobacco]
strengthens the mind, the brain—if previously seeing a
cockroach made me react with fear, now the cockroach is my
pet, as an example”).
The healer describes a tonifying remedy that targets
depression or anxiety conditions specifically. Severe clinical
cases may require treatment between 3 and 6 months, but 1
month of treatment with this remedy is generally sufficient for
milder cases. However, the Tabaquero explains that for certain
types of clients with a chronic nervousness (“nervios crónicos”)
or an overwrought nervous system (“sistema nervioso muy
afectado”), tobacco is contraindicated. He explains that for
such patients, even though their body would be apt to a
tobacco-treatment, there is a potential that their mind reacts to
the tobacco effect with panic or loss of control. Tobacco is also
contraindicated for severe psychotic conditions. In less severe
cases (e.g., mild forms of paranoia), the healer explains that a
plant combination that includes tobacco can help, but that in
most cases, a more structured treatment frame (also involving
counseling) is necessary. Similarly, for highly aggressive or
hostile patients tobacco is contraindicated. The healerOctober 2020 | Volume 11 | Article 594591
Berlowitz et al. Tobacco-Based Treatments in Amazonian Medicineillustrates that for pathologies that feature excessive heat in
the head, such as the former, tobacco may in fact aggravate the
condition, due to the heating quality of the herb. Further, in the
context of substance use disorders, the healer expresses that
although tobacco can help in principle, a more extensive overall
treatment frame is needed, and that for such patients tobacco can
only be prescribed if they are already abstinent: “They are
generally compromised and their brain affected, requiring
another kind of therapy to stop using. After about 6 months
without using the drug, then they can however drink tobacco,”
which will help the detoxification of body and energy, the healer
explains, since the pathology involves both “physical and
energetic ills, and the tobacco cleans these things.” He points
out that for alcoholics, conversely, repeated tobacco ingestion
can be used to help them achieve abstinence. This is also the case
for cigarette smoking cessation: “If the person drinks tobacco
several times over an extended period of time, then he won’t
smoke anymore.” Finally, for psychosomatic pain conditions, the
healer stated that tobacco cannot directly treat such conditions. It
may help indirectly by centering the person’s mind, improving
their sleep and appetite; the pain condition itself, however, will
necessitate additional treatments. In regards to sleep specifically,
the healer adds that topical application of crushed tobacco leaves
on the forehead can be very helpful in cases of insomnia or other
sleep disturbances.
Applications in Amazonian Epistemic
Health Domains and the Tobacco's
Spiritual-Energetic Properties
The healer explains that viewed from the Amazonian medical
understanding, tobacco medicine, in addition to the plant’s
biochemical action, exerts its therapeutic effects via the
energetic and spiritual domains. These domains or aspects of
the human body are significant for pathogenesis “because
illnesses first arise in the spirit-body, then in the energy-body,
and only then manifest in the physical body,” he explains.
Aiming to further elucidate the energy aspect of the body, he
describes that like nerves, the body is permeated by energy
channels, which are in direct relationship with the structures of
body and mind. In his point of view, the key power of the tobacco
plant, thus, lies in its extraordinary capacity to tackle the
spiritual-energetic dimension: “There are many excellent
medicines, but for energetic problems, tobacco is number one.”
He describes that it removes energetic pollutants from the
system, thereby increasing the flow of energy in the body,
which in turn improves health of body and mind.
Furthermore, according to Amazonian epistemologies, there
are illnesses that are expressly related to spirits (noncorporeal
living beings, which can be health- or sickness-promoting). The
tobacco is said to be effective for such illnesses because the plant
itself is associated with a powerfully healing spirit, which
antagonizes malevolent entities: “With tobacco [these kinds of
illnesses] get cured in one go, because demons cannot live where
there is tobacco.”
The healer illustrates the interplay between physical,
psychological, energetic, and spirit-related factors in theFrontiers in Pharmacology | www.frontiersin.org 7description of the immediate effect of tobacco: “Upon ingestion
the tobacco connects to the stomach and, together with its
energetic power, connects to the intestines. From the intestines
it connects to the brain and nervous system and mobilizes the
energy system of the overall body. In the course of this process,
vomiting is triggered. [ … ] So the person tends to vomit, but in
these bouts of vomiting, it is not just vomiting: the patient frees
himself from physical ills, but also—for those that are able to
understand this—from a lot of bad spirits, and is also cleaning his
energetic field. This is what this kind of tobacco that makes one
vomit is aimed for. [… ] Once the person has vomited, they have
freed their mind, heart, intestines, and overall body. There is an
energetic change, the person feels lighter, more joyful, more
calm, with a more loving connection towards nature, things
like that.”
Consequently, the healer reports the utility of tobacco for a
series of health problems which according to Amazonian
epistemics are energetic or spiritual in essence and etiology: for
instance brujerıás, daños, mal del aire, or saladera, which are
different classes of illness that have an accumulation of energetic
pollutants and/or spirit-related problems in common, and can be
treated effectively with tobacco. The person suffering from these
conditions may exhibit a specific symptom pattern (e.g.,
insomnia, diarrhea, paranoia, loss of weight, etc.), but once the
tobacco treatment has expelled the unhealthy spirits and
energetic toxicities from the person’s body, the symptoms
disappear, explains the healer.
Lastly, in the context of the tobacco plant’s spiritual effects,
the healer describes a phenomenon he calls “awakening the
spirit-body” of a person. He explains that aside from the
physical and energy body, every person possesses a spiritual
body, which is a natural aspect of the overall human. Most people
are however unaware of having this part because it is asleep or
sick, he explains. The correct application of tobacco may help
this aspect to awaken or recover, he explains, and that “if it has
awakened, it functions in one’s dreams; the spirit-body starts to
do its work.” The healer strongly emphasizes the personal and
interpersonal significance of awakening one’s spirit-body, as it
brings about more understanding and care of others, more
compassionate and conscious living.
Contraindications, Interactions, Risks, and
Adverse Effects
The healer reports heart diseases, high or low blood pressure, and
severely impaired lungs or other vital organs (e.g., cirrhosis of the
liver), as well as a “greatly affected nervous system” and the
aforementioned mental illnesses as contraindications for
tobacco-treatments. Furthermore, the healer explains that
tobacco should not be taken during pregnancy or lactation. In
terms of drug interactions, the healer mentions antibiotic drugs,
which should not be used in the context of a tobacco treatment
with a time lapse before and after being necessary. Moreover,
recreational drug users may not drink tobacco until they have
ceased usage for at least 6 months. Finally, other powerful
medicinal plants should not be used in conjunction with a
tobacco treatment.October 2020 | Volume 11 | Article 594591
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tobacco-based treatment via the traditional Amazonian
diagnostic techniques, involving i.a. the palpation of a patient’s
pulse (pulsar). Whether the elderly can drink tobacco depends
on their overall strength and health condition in the context of
their age, states the healer: “If a person, for example, is 70 years
old, and has a compromised liver, problems with their prostate, a
lot of age-related health issues, then tobacco is not suited for
them.” Similarly for children, those below 5 years of age are
generally treated via sopladas rather than ingestion (minimal age
of 6 months for treatment with soplada). He explains that
regardless of age, for any Amazonian treatment that requires a
strict dietary regime like tobacco, a certain level of physical
strength is necessary “because a very debilitated body will not
withstand the diet.”
In terms of risks of tobacco treatments, the informant
highlights first and foremost the proficiency of the healer: “The
curandero needs to be a curandero. If a person that is not a
curandero serves tobacco, he can kill the patient. [ … ] The
medicine is very good—that is why it is called ‘medicine’—but
used incorrectly it can kill, like any potent medicine.” He
explains that if a person serves tobacco to a patient that has a
condition for which it is contraindicated, without knowing the
diagnostic methods to determine if a patient is apt for the
treatment, or if the healer does not understand the effects
thoroughly, or does not master the traditional techniques for
intervening if needed, the consequences can be fatal. For
example, some patients may not vomit for certain reasons,
which can be dangerous due to an overheated system; they
may want to lie down or faint, and a tabaquero must recognize
such cases and be able to intervene with the traditional
techniques specifically designed for these situations. Hence, a
skilled and experienced healer is absolutely essential for patient
safety, the tabaquero emphasizes. Finally, if the mandatory
dietary rules of the tobacco treatment are not followed, this
may lead to a series of adverse effects ranging from mild
to intense.
Uses of Tobacco Smoke in the Work of a
Tabaquero and Amazonian Medicine
“Tobacco in smoked form has energetic purposes,” says the
healer, and describes sophisticated techniques, with different
areas of application. The smoke is swallowed to the stomach,
he points out, not inhaled to the lungs. He highlights that, in
order to be able to use tobacco for healing work, an apprenticing
tabaquero must first prepare his/her body with the ingestion of
medicinal plants in the context of long-term dietary retreats
(dietas). Furthermore, the trainee must learn the techniques for
soplar (blowing smoke) and icarar (specific chanting for healing
purposes). Soplar and icarar are key for what the healer calls
“directing the medicine”: Together they function like a vector,
linking the curative forces of the healer with the medicinal
properties of the plants and imparting it a direction that guides
the therapeutic process. He describes these techniques as an
integral part of the therapeutic success: “It is part of the
treatment, part of the efficacy of the treatment of the sickFrontiers in Pharmacology | www.frontiersin.org 8person’s body. [ … ] If the medicine normally can cure 30%,
the curandero by means of his icaro and soplada adds another
70% of therapeutic force.” Furthermore, a curandero may blow
smoke (soplar) directly onto a patient’s body to “help a sick
person rest and recover their energy.” The smoke applied by the
healer in this manner is said to have a protective function “like a
shield on your outer body.” He uses a variety of techniques for
this: “There are manners of soplar, a curandero knows where he
needs to blow. There are points on the body where the smoke
needs to be blown. [ … ] These are energetic points, a bit like
acupuncture, for example.” He explains that a healer can treat
specific illnesses in this manner, for example susto, which is a
type of fright or startle response that disrupts the person’s
energy system.
Finally, when asked about the difference between smoke that
is therapeutic and smoke that is harmful, the healer responds
that, first, the tobacco used in industrial cigarettes is poisonous:
“The tobacco companies have adulterated the tobacco, adding
chemicals. And these chemicals are destructive for the entire
human being, from head to toe.” He believes this has been done
for financial reasons, so that the people would buy more, like
with drugs. “In our case here, the tabaquero has the tobacco
plant, and [cured with] alcohol of the sugarcane, it is all natural,
no chemicals beyond the natural ones of the plant.” Second, he
points to the difference in manner of usage: “The curandero does
not smoke for pleasure, there is a purpose. [ … ] He smokes
when it is necessary.” When asked if the smoking of a tabaquero
may eventually have negative health consequences for the
tabaquero himself, he explained that a tabaquero undergoes a
long-term preparation during his/her apprenticeship for this
purpose, preparing the body with specific medicinal plants and
diets, so that his body can withstand the work with tobacco. For
someone without this preparation, he considers it indeed
potentially harmful to use tobacco in that manner.
Tobacco in Relation to Other Amazonian
Medicinal Plants
Tobacco has a unique place in Amazonian medicine, explains the
healer, in that it is the one plant used to direct or potentiate the
others: “All plant remedies have to be blown with tobacco
smoke” before giving them to the patient, says the healer.
Because of its healing scope and due to its spiritual-energetic
force, he considers tobacco as a sort of royal herb among
medicinal plants: “The tobacco’s healing power in the energetic
realm is outstanding; I have worked with many other power
plants, very good ones, but none of them compared to tobacco in
this context.” He also describes that tobacco is closely connected
to the “tree medicines” used in the Amazonian tradition, which
are also fundamental, he explains, by giving strength and stability
to a patient. When asked about the difference between tobacco
and ayahuasca (given that the latter is very popular in the world
currently), he said that “tobacco centers your mind while
ayahuasca produces visions and fantasies.” He considers that
without adequate preparation, it is very difficult for most people
to differentiate between the reality and the fantasies of their own
mind, which is a problem or risk in ayahuasca. He points out thatOctober 2020 | Volume 11 | Article 594591
Berlowitz et al. Tobacco-Based Treatments in Amazonian Medicineif given to the right patient by an adequately trained healer, both
medicines are very valuable. However, he considers that most
people using ayahuasca currently are ill-prepared for working
with this plant, as this requires an extensive preparation period,
which they have not undertaken. “Ayahuasca is very good, but it
has to be given by healers who know, who have trees in their
body, and have prepared themselves and can direct the work. Not
by just anyone. Because today the world is full, there are many
who have taken ayahuasca 10 times and are already shamans,
and serving ayahuasca—it does not work like that.” He therefore
considers there to exist a lot of misguided practice and
misunderstandings around this plant at present.DISCUSSION
The current study described Amazonian therapeutic uses of
tobacco (N. rustica L.) in the practice of a Maestro Tabaquero,
an accomplished Amazonian healer specializing in tobacco-
based treatments. The informant’s descriptions revealed refined
knowledge on the plant’s therapeutic scope and properties, safety
profile, and application techniques. A liquid remedy taken orally
was his most commonly used preparation, with reported acute/
sub-acute effects involving a pronounced psychoactive
component (altered state of consciousness) and physiological
response (emesis, intoxication, Spanish: “mareación”). A skilled
tabaquero that knows how to diagnose, dose, administer, and
intervene in case of adverse effects was described as imperative
for safe treatment delivery; tobacco ingestion otherwise may be
dangerous. The main indications mentioned by the informant
included problems of the mind, of the respiratory system,
parasitic illnesses (intestinal/skin), gout, and Amazonian
epistemic conditions described as spiritual-energetic in nature.
The stated key indication to treat “problems of the mind,”
together with the effects described by our informant as “opening
of the psychic-mental,” suggest parallels to psychedelic-assisted
therapies, a rapidly growing trend in current psychiatry research
(Tupper et al., 2015; Garcia-Romeu et al., 2016; Johnson et al.,
2019). Such therapies involve the administration of psychoactive
substances (e.g., psilocybin, ayahuasca) to treat mental health
problems, with promising results reported for instance for mood,
anxiety, addictive, or neurological disorders (Baumeister et al., 2014;
Thomas et al., 2017; Palhano-Fontes et al., 2018; Davies and
Bhattacharyya, 2019; Butler et al., 2020). Although there is no
doubt that tobacco is psychoactive, there has been debate as to the
specific class of psychoactive substances it falls. While reported
tobacco uses in shamanism involve trances and visions, thus
suggesting the plant as a hallucinogen/psychedelic (Janiger and de
Rios, 1973; Janiger and de Rios, 1976; Wilbert, 1993), research on
nicotine, the tobacco alkaloid mainly studied in this context,
considers tobacco a stimulant/depressant (Levin et al., 1998;
Picciotto et al., 2002). Neuroscientific studies point to complex
actions of nicotine on human cognition, with cognitive-enhancing
effects in attentional and memory processes (Valentine and
Sofuoglu, 2018). However, nicotine is by no means the only
alkaloid or active constituent of the tobacco plant, and tobacco-Frontiers in Pharmacology | www.frontiersin.org 9induced effects might differ from the effects of nicotine alone in
significant ways (Hoffmann and Wynder, 1986; Leffingwell, 1999;
Charlton, 2004). For instance, aside from nornicotine, anatabine,
and anabasine (Benowitz et al., 2009), the b-carbolines harman and
norharman which act as monoamine oxidase (MAO) inhibitors
have also been reported in tobacco (Janiger and de Rios, 1976;
Herraiz and Chaparro, 2005). MAO-inhibiting b-carbolines are
currently investigated for their antidepressant effects (Ferraz et al.,
2019) and are present also in the Amazonian ayahuasca brew. In
fact, their synergistic interaction with other alkaloids of the brew
play a key role in the psychopharmacology of ayahuasca (Riba et al.,
2003; Palhano-Fontes et al., 2018). Hence, in addition to nicotine,
other constituents of tobacco might be critically involved in the
psychoactivity of oral tobacco. Overall, and as our findings also
imply, the nature of tobacco effects may crucially depend on the
plant material used, its preparation and ingredients added, as well as
the context of administration (see also concept of “set and setting”
in psychoactive plant use, Hartogsohn, 2017). In the case of our
informant’s described “strong preparation” (ceremonial or retreat
format), broad parallels to other psychedelic-assisted therapies are
clearly evident (altered states, spiritual/peak experiences; mental
health indications; high levels of anxiety or psychotic features as
contraindications), but experimental studies that assess subjective
effects directly are needed. Interestingly, the healer’s descriptions of
the tobacco effect as centering the mind or aligning are also
somewhat evocative of mindfulness concepts. Originally
stemming from Buddhist meditative practices, mindfulness-based
interventions are common in contemporary psychotherapy to treat
depression, chronic pain, or stress reduction (Kabat-Zinn, 2003;
Fjorback et al., 2011).
Noteworthy is further the healer’s account of a direct link
between intestines and brain involved in the therapeutic
mechanism of ingested tobacco, and its beneficial effects on
mental parameters related to its action in the gut (expelling of
intestinal parasites). The description is in line with the scientific
understanding of the gut-brain axis, a close relationship between
gut health and brain functioning, whereby alterations in gut
microbiota may influence psychological health (Mayer, 2011;
Foster and McVey Neufeld, 2013; Mayer et al., 2015). Emerging
therapies based on this relatively recent understanding are
testing for instance probiotics to treat clinical depression
(Nikolova et al., 2019). Beyond its direct action in the
neurosystem, nicotine is also known to alter the gut
microbiome (Chi et al., 2017) and tobacco’s antiparasitic
properties in general are well-documented (Schorderet Weber
et al., 2019). At a more basic level, the healer’s description of link
between gut and brain may also express the pharmacological
process of active tobacco constituents reaching the brain via
blood pathways after gastrointestinal absorption (oral route).
Bearing in mind the aforementioned caveat that the tobacco
remedy may not be equated to nicotine alone, the choice of route
of administration is interesting, given absorption of nicotine via
the oral route is subjected to first-pass metabolism, with only a
fraction of ingested material reaching the brain (Benowitz et al.,
2009; Alkam and Nabeshima, 2019). Pulmonary absorption via
smoking would be more effective in terms of nicotine levels,October 2020 | Volume 11 | Article 594591
Berlowitz et al. Tobacco-Based Treatments in Amazonian Medicinewhich suggests the maximization thereof not to be the main
objective or priority of this tobacco therapy, nor the
minimization of symptoms of intoxication like vomiting. The
latter is in fact a deliberately sought effect of the tobacco remedy:
from the Amazonian perspective it is considered an inherent part
of the therapeutic mechanism. Lastly, nicotine also has
peripheral vasoconstrictive or bronchoconstrictive effects
(Alkam and Nabeshima, 2019), which is in line with the
healer’s stated contraindications regarding blood pressure and
heart or severe lung diseases. It may appear to contrast with his
description of increased oxygen flow, however, rather than
referring to a direct effect, the latter was stated as an indirect
consequence resulting from the tobacco’s removal of phlegm/
blockages and subsequent opening of pathways/mind, a process
the healer subsumed as “increased oxygen flow.”
Finally, the Amazonian epistemic concepts that play a role in
tobacco-based treatments as per our informant are consistent
with traditional Amazonian conceptions of healing and sickness
in general (e.g., concept of plants with agency, concept of
spiritual/energetic factors in pathogenesis and treatment; Luna,
1984; Lenaerts, 2006; Jauregui et al., 2011; Berlowitz et al., 2017).
The use of emetic plants and idea of vomiting not as an
undesirable side effect, but as key component of therapeutic
effectiveness, is characteristic in Peruvian Amazonian medicine
(see Sanz-Biset and Canigueral, 2013, for a description of
depurative practices in Amazonian medicine) and the concept
can be found also in other traditional medicines (e.g., Ayurveda,
Bhatted et al., 2011; Vinjamury et al., 2012). The usage of tobacco
smoke on the body (soplada) might have certain parallels with
the practice of moxibustion (application of burning Artemisia
vulgaris/other herbs on acupoints; Deng and Shen, 2013), the
energy channels in the body mentioned by the healer reminiscent
of the meridian systems in Asian medicines. The informant used
the terms energy/energetic and spirit/spiritual in varying contexts
in his descriptions. While the former generally denoted subtle
vitality forces of the body, the latter was used to describe a
noncorporeal (“essence”) aspect of self, or “spirits” in the sense of
noncorporeal others which are in interrelationship with humans
(see also Amazonian animist ontologies; Viveiros de Castro,
1998; Rosengren, 2006; Santos-Granero, 2006). The tabaquero’s
description of etiology of diseases, which “first arise in the spirit-
body, then in the energy-body, and only then manifest in the
physical body,” is interesting in conjunction with his stated mode
of action of tobacco in terms of its effectiveness in the spiritual/
energetic domain: It implies that from the Amazonian epistemic
perspective, tobacco has the capacity to intervene in the process
of pathogenesis at a level more fundamental than the physical.
This may provide the rationale for the healer’s declared
supremacy of the plant (“royal plant”), which is in line with
ethnographic accounts of tobacco’s central role in Amazonian
healing (e.g., “father of all plants”) and in the etymology of the
healer-term in indigenous Amazonian languages (e.g., “he who
eats tobacco”), as outlined in the introductory section (Shepard,
1998; Rosengren, 2006; Barbira-Freedman, 2010; Thomas et al.,
2011; Russell and Rahman, 2015; Barbira-Freedman, 2015). It
also is in line with the prominence of tobacco uses in otherFrontiers in Pharmacology | www.frontiersin.org 10Amerindian cultures across the Americas (Wilbert, 1993;
Groark, 2010; Russell and Rahman, 2015; Rodrıǵuez Arce and
Cerdas, 2019), where it has long been a highly esteemed plant, its
consciousness-altering effects harnessed by shamans for
divination, sorcery, healing, or spiritual purposes since
millennia (Janiger and de Rios, 1973; Zethelius and Balick,
1982; Wilbert, 1991; Echeverrı ́a and Niemeyer, 2013;
Tushingham et al., 2018). Finally, also consistent with our
findings are reports of indigenous tobacco uses in horticulture
(as an insecticide) and in veterinary medicine, or to improve
dogs’ hunting skills (Wilbert, 1993; Bennett and Alarcón, 2015).
The healer reports using tobacco leaves that have been cured
with sugarcane alcohol, a procedure that is aimed to obtain a
tobacco of high medicinal value or efficiency that can be
conserved in the hot/damp climatic conditions of the Amazon.
This is in contrast to tobacco cured with sweet sugarcane
derivatives in other contexts (e.g., usage of molasses in the
Indian sub-continent), that flavor the tobacco to enhance the
pleasurable experience of smoking (Talhout et al., 2006).
This work has several limitations. We opted for a single-
respondent design, conducting repeated in-depth interview
sessions with a carefully selected informant. This had
advantages from a clinical point of view (generating data of
great detail and depth) but came at the cost of generalizability
across healers or cultures. As a consequence, our findings give
insight into the practice of a highly accomplished expert in this
field, but a broader, cross-ethnic interview study would be
needed to know if they are representative of Peruvian-
Amazonian tobacco uses in a more general sense. More
importantly from a clinical perspective, the qualitative expert
interview approach (Bogner and Menz, 2009) we used should be
complemented with case reports and a direct quantitative
assessment of patients, as a next step. To our knowledge, this
is the first study employing a transdisciplinary clinical focus to
examine therapeutic applications of tobacco by an Amazonian
tabaquero. Our findings significantly contribute to the growing
research literature on Amazonian medicine and on emergent
psychedelic-assisted therapies and could, in the long-term, open
new treatment avenues in several domains. Forthcoming studies
should assess toxicity/safety and clinical outcomes of patients
receiving Amazonian tobacco-based treatment.DATA AVAILABILITY STATEMENT
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